BioHealth News Archive
Sands Capital, Accolade Partners and more funds are raising money. Here’s what’s driving it. – Washington Business Journal
In Greater Washington, we spotlight these VC firms raising new funds or adding dollars to their existing ones. {iframe}https://www.bizjournals.com/washington/news/2021/07/01/sands-capital-accolade-partners-raising-new-funds.html{/iframe}
Read MoreLife Sciences Markets Eye ‘Transformative’ New Federal Investments
Arriving in Washington in the midst of a pandemic, the Biden administration has been laser-focused on funding life sciences, announcing support for the onshoring of…
Read More
Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021
By the end of this week, the world should cross two small but significant milestones on the road to overcoming COVID-19—getting at least 5%…
Read More
Qiagen and Sysmex Team up on Cancer Companion Diagnostics | mddionline.com
The companion diagnostics market is on track to reach $6.8 billion by 2025 (from $3.7 billion in 2020), according to a Markets and Markets…
Read More
MIMETAS and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development
LEIDEN, The Netherlands, July 06, 2021 / B3C newswire / -- MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading…
Read More
BioTalk with Rich Bendis welcomes Howard Carolan, CEO of CoapTech, and Neil Davis, Program Director at University of Maryland Baltimore
Howard Carolan, Co-Founder and CEO of CoapTech, Inc., and Neil Davis, Program Director of the Biomedical Entrepreneurship Graduate Certificate program at the University of…
Read More
Seven Up-and-Coming COVID-19 Drugs
Thanks to unprecedented development speed and mostly strong safety and efficacy data, vaccines have dominated the response to COVID-19. But ending the pandemic will…
Read More
Kinexum ATTD 2021 report.pdf(Shared)- Adobe Document Cloud
This document has been redacted by Sam Collaudin, Kinexum Business Strategy Consultant, independently from any pharmaceutical and biotech companies It synthesizes selected data presented…
Read MoreMoney Moves: It’s a big investment week for Frederick companies – Technical.ly Baltimore
This week, a pair of Frederick companies raised millions in new investment, offering evidence of the Maryland city’s growing role as one of the…
Read MoreRon Daniels’ tenure as Johns Hopkins University president extended through 2029 | Hub
Johns Hopkins University's board of trustees has voted unanimously to add a new five-year term to the presidential tenure of Ron Daniels, an extension…
Read More
Vigene Biosciences closes deal to be acquired by Charles River Laboratories – Washington Business Journal
The firm helps gene therapy and vaccine companies develop and manufacture products for rare diseases. Image: Vigene Biosciences, led by CEO Zairen Sun, right,…
Read More
Adaptive Phage Therapeutics Expands Board Following Series B Financing Led by Deerfield Management | Business Wire
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced the appointment of…
Read More
DC Region’s Life Sciences Sector Is on the Rise – Commercial Observer
Go pakh your cahr, Boston. Grab some granola, California. It’s D.C.’s moment in life sciences. For years, the Washington metropolitan area has been one…
Read More
Startup Professionals Musings: 6 New Venture Realities To Target Your Funding Effort
Entrepreneurs who require funding for their startup have long counted on self-accredited high net worth individuals (“angels”) to fill their needs, after friends and…
Read More
My View: Angel investor extension means business for Arizona – Phoenix Business Journal
Since 2005, the Small Business Capital Investment Incentive has generated early-stage funding for more than 200 Arizona businesses, including my company, Qwick. I moved…
Read More